Ascendis Pharma (ASND) PT Raised to $163 at Citi
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $255.46 --0%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 6
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 6
Join SI Premium – FREE
Citi analyst David Lebowitz raised the price target on Ascendis Pharma (NASDAQ: ASND) to $163.00 (from $157.00) while maintaining a Buy rating.
You May Also Be Interested In
- ICICI Securities Downgrades Landmark Cars (LANDMARK:IN) to Add (2)
- Sun TV Networks Ltd. (SUNTV:IN) PT Lowered to INR542 at Axis Capital Limited
- Jyothy Laboratories Ltd. (JYL:IN) PT Lowered to INR205 at Axis Capital Limited
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
